X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

    Clinical Development

    AI Revolutionizing Drug Discovery and Clinical Development

    Drug-Development

    China’s Super Me-Too Drug Development: A New Pharma Frontier

    Omics Based Clinical Trials

    Asia Pacific Omics-Based Clinical Trials Market Growth

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home News

CDC Suggests Majority of Americans Have COVID-19 Antibodies

Content Team by Content Team
3rd May 2022
in News
Ensovibep Therepeutic Candidate To Fight COVID-19 Makes Way

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

According to updated information from the US Centers for Disease Control and Prevention, about 60% of adults plus 75% of children have antibodies suggesting that they’ve been exposed to COVID-19.

The information comes from a long-term examination of blood specimens sent out to commercial labs across the United States. At the beginning of December, an estimated 34% of Americans had antibodies suggesting that they had been exposed to the virus that induces Covid-19. After an outpouring of cases caused by the Omicron strain, that number had grown to 58 percent by the end of February. Dr. Kristie Clarke, a paediatrician who headed the study for the CDC, said, the biggest surge in antibody detection was among children and teens.

According to the study, over 75% of kids under the age of 18 had acquired antibodies to COVID-19 by February. Adults 65 and older saw the lowest rise, with the CDC estimating that 33 percent of elders have indeed been affected by the virus. However, it’s unknown what these test results indicate in terms of personal or community resistance to future diseases. Researchers really don’t know how much longer virus-induced immunity lasts, and one can’t tell from the study whether all people who screened positive for SARS-CoV-2 antibodies are still shielded from their previous infection, Clarke said.

As a result, the CDC advises that all Americans keep up to date on their COVID-19 immunizations and receive the required shots and boosters. Clarke says people who have been diagnosed within the last three months may be willing to wait on their second booster shot.

The figures are based on random, anonymous blood tests conducted by commercial laboratories in the United States. The testing detects antibodies to components of the virus that causes COVID-19; as vaccinations do not produce these antibodies, the testing is used to determine how many people have been infected with the SARS-CoV-2 virus. According to the CDC, the antibodies used in the study stay positive for at least 2 years following exposure, indicating that the study should capture infections that have occurred since the start of the pandemic.

According to Clarke, the CDC does not advise anyone to get an antibody test. They don’t encourage this on an individual basis, she explained, since it doesn’t change the advice in terms of what one should do, such as getting the vaccines up to date and addressing other precautionary actions with the doctor.

The research comes as more contagious new strains, BA.2 and BA.2.12.1, are taking control of transmission in the United States, producing more cases and hospitalizations. Dr. Rochelle Walensky, director of the Centers for Disease Control and Prevention, said that the department is closely monitoring COVID-19 instances in the Northeast. They are seeing a larger number of cases in various parts of the country, especially in the Northeast, and they are also beginning to see some hospital admissions go up, she added.

Walensky explained that the numbers had not risen as quickly as they would have previously in the pandemic, thanks to, she believes, a great level of community protection and vaccinations. However, one must keep a close eye on this, she explained.

Previous Post

Camzyos, Possible Mega Cardiac Drug Given Green Light By FDA

Next Post

Teva And Lupin Reach Settlement In AUSTEDO Patent Dispute

Related Posts

WuXi Biologics and Virogen Bio partner to advance VG712
News

WuXi Biologics and Virogen Bio partner to advance VG712

19th June 2025
Construction of WuXi Biologics Microbial Manufacturing Site
News

Construction of WuXi Biologics Microbial Manufacturing Site

19th June 2025
Beyfortus From Sanofi to Make Imprint in 2025 26 RSV Season
News

Beyfortus From Sanofi to Make Imprint in 2025-26 RSV Season

19th June 2025
Thermo-Fischer-Accelerator Drug Development an Ideal Choice
News

Thermo Fischer Accelerator Drug Development an Ideal Choice

19th June 2025
IQVIA Custom Built AI Agents for Life Sciences Healthcare
News

IQVIA Custom-Built AI Agents for Life Sciences, Healthcare

19th June 2025
SCHOTT Pharma Invests
News

SCHOTT Pharma Invests EUR 100 Million in RTU Cartridges

9th June 2025
Next Post

Teva And Lupin Reach Settlement In AUSTEDO Patent Dispute

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In